Medpace Holdings Inc
- Industria
- Pharma Outsourcing (CRO)
- Bolsa
- EE. UU.
- País / Región
- USA
- Fecha de salida a bolsa
- 11 de agosto de 2016
- Empleados
- 6300
- Sitio web
- www.medpace.com
Rango de valoración compuesto · conservador $290–$360 / razonable $380–$460 / optimista $520–$600. A $460.2, Entre el rango razonable y el optimista.
Al publicar $454.25 (6 de junio de 2026)
Aún no hay análisis sobre este valor en tu idioma.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Datos de EODHD, mostrados en la moneda de reporte; solo a título informativo, no constituye asesoramiento de inversión.
Historia
PróximamenteEsta sección se está completando; vuelve pronto.
Posición en el sector
PróximamenteEsta sección se está completando; vuelve pronto.
